[HTML][HTML] Community transmission and viral load kinetics of the SARS-CoV-2 delta (B. 1.617. 2) variant in vaccinated and unvaccinated individuals in the UK: a …
…, A Lalvani, A Badhan, S Dustan… - The lancet infectious …, 2022 - thelancet.com
Background The SARS-CoV-2 delta (B.1.617.2) variant is highly transmissible and spreading
globally, including in populations with high vaccination rates. We aimed to investigate …
globally, including in populations with high vaccination rates. We aimed to investigate …
[HTML][HTML] Risk factors and vectors for SARS-CoV-2 household transmission: a prospective, longitudinal cohort study
…, H Catchpole, A Badhan, S Dustan… - The Lancet …, 2023 - thelancet.com
Background Despite circumstantial evidence for aerosol and fomite spread of SARS-CoV-2,
empirical data linking either pathway with transmission are scarce. Here we aimed to assess …
empirical data linking either pathway with transmission are scarce. Here we aimed to assess …
[HTML][HTML] DNA extraction columns contaminated with murine sequences
O Erlwein, MJ Robinson, S Dustan, J Weber, S Kaye… - PLoS …, 2011 - journals.plos.org
Sequences of the novel gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV)
have been described in human prostate cancer tissue, although the amounts of DNA …
have been described in human prostate cancer tissue, although the amounts of DNA …
Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia
N Mackie, S Dustan, MO McClure, JN Weber… - Journal of virological …, 2004 - Elsevier
We modified the Abbott diagnostics HIV-1 Viroseq version 2 assay™ in order to detect the
presence of HIV-1 drug resistance mutations in patients with viraemia below 1000 copies/ml of …
presence of HIV-1 drug resistance mutations in patients with viraemia below 1000 copies/ml of …
Prevalence of primary genotypic resistance in a UK centre: comparison of primary HIV-1 and newly diagnosed treatment-naive individuals
J Fox, S Hill, S Kaye, S Dustan, M McClure, S Fidler… - Aids, 2007 - journals.lww.com
The worrying finding that up to 19% of newly diagnosed HIV-1 cases in the UK have genotypic
evidence of transmitted drug-resistant HIV-1 (TrDR-HIV-1) does not concur with levels …
evidence of transmitted drug-resistant HIV-1 (TrDR-HIV-1) does not concur with levels …
[HTML][HTML] Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz+ tenofovir+ emtricitabine for HIV
Objectives The aim of this study was to investigate associations between baseline characteristics
and CD4 cell count response on first-line antiretroviral therapy and risk of virological …
and CD4 cell count response on first-line antiretroviral therapy and risk of virological …
Development of highly specific singleplex and multiplex real-time reverse transcription PCR assays for the identification of SARS-CoV-2 Omicron BA. 1, BA. 2 and …
The Omicron variant of SARS-CoV-2 (B.1.1.529), first identified during November 2021, is
rapidly spreading throughout the world, replacing the previously dominant Delta variant. …
rapidly spreading throughout the world, replacing the previously dominant Delta variant. …
Continuation of emtricitabine/lamivudine within combination antiretroviral therapy following detection of the M184V/I HIV‐1 resistance mutation
Objectives The aim of the study was to investigate whether lamivudine (3TC) or emtricitabine
(FTC) use following detection of M184V/I is associated with better virological outcomes. …
(FTC) use following detection of M184V/I is associated with better virological outcomes. …
Comparative hepatitis C genotype 1-3 viral load kinetics in response to directly-acting antiviral therapy
…, T Delahooke, FY Lai, S Dustan… - The Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
… 5 , Simon Dustan …
Evidence‐based veterinary medicine: new graduates' perspectives
L Spoor, S Priestnall, J Claridge, B Dustan… - In Practice, 2009 - Wiley Online Library
… Ben Dustan: In modern-day veterinary practice I would suggest EBVM is highly relevant,
if not … Ben Dustan: I believe that any difference that exists is more related to the sources of …
if not … Ben Dustan: I believe that any difference that exists is more related to the sources of …